The global sterile filtration market size is projected to reach USD 7.4 billion by 2025 from USD 4.7 billion in 2019, at a CAGR of 8.0% during the forecast period. The major factors driving the growth of this market include the advantages of sterile filters over non-sterile filters, the growing demand for pure water in the end-user market, increasing adoption of single-use technologies, and rising focus on the development of large biopharmaceutical drugs. However, the high price sensitivity among end users is a major challenge expected to restrain the growth of the market.
The major players in the sterile filtration market include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), 3M (US), and Parker Hannifin Corporation (US). These players have adopted various growth strategies such as product launches, acquisitions, agreements, partnerships, and expansions to increase their presence in the global sterile filtration market.
To know about the assumptions considered for the study download the pdf brochure
Merck KGaA (Germany) is the leading player in the global sterile filtration market. The company offers a wide range of sterile filtration products through its Process Solutions business segment. The Process Solutions segment of the company is the most dynamic business unit; wherein in 2018, it contributed the largest share (~40%) to the company’s organic sales and witnessed double-digit growth (~16%) from the previous year. The significant contribution and continuous growth of this segment are primarily due to Merck’s strong product portfolio, brand recognition, and high demand for bioprocessing technologies (inclusive of sterile filtration products), particularly in North America and the Asia Pacific region. The demand for sterile filtration products heavily depends on the sales of biopharmaceutical companies as well as on the productivity of their research & development activities. The company also adopts organic strategies such as product launches and expansions in order to maintain its position in this market. In 2017, Merck Millipore made several announcements, including the launch of its new product—the Stericup Quick Release 500 ml Vacuum Filtration System—and the establishment of its Mobius single-use manufacturing facility in China and India. With such strategic initiatives, Merck is most likely to retain its leading position in the sterile filtration market in the coming years.
Danaher (US) is the second-largest player in the global sterile filtration market. Danaher provides filtration, separation, and purification technologies for the medical, biopharmaceutical, and food & beverage industries through its subsidiary, Pall Corporation (a part of the Life Sciences business). Danaher operates as one of the top players in the sterile filtration market with its strong portfolio of sterile filters, inclusive of membranes, syringe filters, vacuum devices, and large-molecular capsules. The company’s filtration, separation, and purification technologies facilitate the development & commercialization of chemically synthesized and biologically derived drugs, plasma, and vaccines. The sales growth of these technologies contributes to the high demand for Danaher’s sterile filtration from the biopharmaceutical industry and various academic & research institutes in Western Europe, North America, and other high-growth markets, specifically in the Asia Pacific region.
Related Reports:
Sterile Filtration Market by Product (Cartridge, Capsule, Syringe), Application (Fill Finish Process, Bioburden Reduction), Membrane (Nylon, PTFE, PES, PVDF), Pore Size (0.2 Microns), End User (Pharmaceutical, Biotechnology, F&B) - Global Forecast to 2025
Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]